Predicting smoking relapse with a multidimensional versus a single-item tobacco craving measure

Drug and Alcohol Dependence

Volumn 132, Issue 3, 2013, Pages 513-520

  Berlin, Ivan ^a   Singleton, Edward G ^b   Heishman, Stephen J ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b MayaTech Corporation   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Prognostic markers; Screening; Smoking relapse; Tobacco craving

Indexed keywords

NICOTINE;

12 ITEM TOBACCO CRAVING QUESTIONNAIRE; ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; MINNESOTA NICOTINE WITHDRAWAL SCALE; OUTCOME ASSESSMENT; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SELF REPORT; SENSITIVITY AND SPECIFICITY; SMOKING; SMOKING CESSATION; VALIDITY;

NICOTIANA TABACUM;

PROGNOSTIC MARKERS; SCREENING; SMOKING RELAPSE; TOBACCO CRAVING;

ADOLESCENT; BEHAVIOR, ADDICTIVE; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RECURRENCE; SMOKING; SMOKING CESSATION; YOUNG ADULT;

EID: 84883553048     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.03.017     Document Type: Article

References (84)

1. Al'absi M., Hatsukami D., Davis G.L., Wittmers L.E. Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug Alcohol Depend. 2004, 73:267-278.
2. Allen S.S., Bade T., Hatsukami D., Center B. Craving, withdrawal, and smoking urges on days immediately prior to smoking relapse. Nicotine Tob. Res. 2008, 10:35-45.
3. Andresen E.M. Criteria for assessing the tools of disability outcomes research. Arch. Phys. Med. Rehabil. 2000, 81:S15-S20.
4. Aubin H.J., Bobak A., Britton J.R., Oncken C., Billing C.B., Gong J., Williams K.E., Reeves K.R. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised, open-label trial. Thorax 2008, 63:717-724.
5. Aubin H.J., Peiffer G., Stoebner-Delbarre A., Vicaut E., Jeanpetit Y., Solesse A., Bonnelye G., Thomas D. The French Observational Cohort of Usual Smokers (FOCUS) cohort: French smokers perceptions and attitudes towards smoking cessation. BMC Public Health 2010, 10:100.
6. Bagot K.S., Heishman S.J., Moolchan E.T. Tobacco craving predicts lapse to smoking among adolescent smokers in cessation treatment. Nicotine Tob. Res. 2007, 9:647-652.
7. Baile W.F., Bigelow G.E., Gottlieb S.H., Stitzer M.L., Sacktor J.D. Rapid resumption of cigarette smoking following myocardial infarction: inverse relation to MI severity. Addict. Behav. 1982, 7:373-380.
8. Berlin I., Singleton E.G. Nicotine dependence and urge to smoke predict negative health symptoms in smokers. Prev. Med. 2008, 47:447-451.
9. Berlin I., Vorspan F., Singleton E.G., Warot D., Notides C., Heishman S.J. Reliability and validity of the French version of the Tobacco Craving Questionnaire. Eur. Addict. Res. 2005, 11:62-68.
10. Berlin I., Singleton E.G., Heishman S.J. Validity of the 12-item French version of the Tobacco Craving Questionnaire in treatment-seeking smokers. Nicotine Tob. Res. 2010, 12:500-507.
11. Berlin I., Jacob N., Coudert M., Perriot J., Schultz L., Rodon N. Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial-a randomized study in smokers with medical comorbidities. Addiction 2011, 106:833-843.
12. Brody A.L., Cook I.A. Manipulation of cigarette craving with transcranial magnetic stimulation. Biol. Psychiatry 2011, 70:702-703.
13. Burling T.A., Singleton E.G., Bigelow G.E., Baile W.F., Gottlieb S.H. Smoking following myocardial infarction: a critical review of the literature. Health Psychol. 1984, 3:83-96.
14. Chinn S. A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat. Med. 2000, 19:3127-3131.
15. Cofta-Woerpel L., McClure J.B., Li Y., Urbauer D., Cinciripini P.M., Wetter D.W. Early cessation success or failure among women attempting to quit smoking: trajectories and volatility of urge and negative mood during the first postcessation week. J. Abnorm. Psychol. 2011, 120:596-606.
16. Cohen L.M., McCarthy D.M., Brown S.A., Myers M.G. Negative affect combines with smoking outcome expectancies to predict smoking behavior over time. Psychol. Addict. Behav. 2002, 16:91-97.
17. Cook N.R. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin. Chem. 2008, 54:17-23.
18. Copeland A.L., Brandon T.H., Quinn E.P. The Smoking Consequences Questionnaire - Adult: Measurement of smoking outcome expectancies of experienced smokers. Psychol. Assess. 1995, 7:484-494.
19. Cox L.S., Tiffany S.T., Christen A.G. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob. Res. 2001, 3:7-16.
20. Doherty K., Kinnunen T., Militello F.S., Garvey A.J. Urges to smoke during the first month of abstinence: relationship to relapse and predictors. Psychopharmacol. (Berl.) 1995, 119:171-178.
21. Elfeddali I., Bolman C., Mesters I., Wiers R.W., de Vries H. Factors underlying smoking relapse prevention: results of an international Delphi study. Health Educ. Res. 2010, 25:1008-1020.
22. Epstein D.H., Marrone G.F., Heishman S.J., Schmittner J., Preston K.L. Tobacco, cocaine, and heroin: craving and use during daily life. Addict. Behav. 2010, 35:318-324.
23. Ertan T., Yoldas O., Kilic Y.A., Kilic M., Göcmen E., Koc M., Tez M. External validation of prognostic models among cancer patients undergoing emergency colorectal surgery. Am. J. Surg. 2008, 195:439-441.
24. Etter J.F. A self-administered questionnaire to measure cigarette withdrawal symptoms: the Cigarette Withdrawal Scale. Nicotine Tob. Res. 2005, 7:47-57.
25. Etter J.F., Hughes J.R. A comparison of the psychometric properties of three cigarette withdrawal scales. Addiction 2006, 101:362-372.
26. Ewing J.A. Detecting alcoholism: the CAGE Questionnaire. JAMA 1984, 252:1905-1907.
27. Galloway G.P., Singleton E.G. How long does craving predict use of methamphetamine? Assessment of use one to seven weeks after the assessment of craving: craving and ongoing methamphetamine use. Subst. Abuse 2009, 26:63-79. The Methamphetamine Treatment Project Corporate Authors.
28. Galloway G.P., Singleton E.G., Buscemi R., Baggott M.J., Dickerhoof R.M., Mendelson J.E. An examination of drug craving over time in abstinent methamphetamine users. Am. J. Addict. 2010, 19:510-514. The Methamphetamine Treatment Project Corporate Authors.
29. Hajek P., Stead L., West R., Jarvis M., Lancaster T. Relapse prevention interventions for smoking cessation. Cochrane Database Syst. Rev. 2009, 1:CD003999.
30. Harrell F.E., Lee K.L., Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 1996, 15:361-387.
31. Harrington N. The craving factor in the treatment of smoking. Br. J. Soc. Clin. Psychol. 1978, 117:363-371.
32. Heffner J.L., Lee T.C., Arteaga C., Anthenelli R.M. Predictors of post-treatment relapse to smoking in successful quitters: pooled data from two phase III varenicline trials. Drug Alcohol Depend. 2010, 109:120-125.
33. Heishman S.J., Singleton E.G., Liguori A. Marijuana Craving Questionnaire: development and initial validation of a self-report instrument. Addiction 2001, 96:1023-1034.
34. Heishman S.J., Singleton E.G., Moolchan E.T. Tobacco Craving Questionnaire: reliability and validity of a new self-report instrument. Nicotine Tob. Res. 2003, 53:75-81.
35. Heishman S.J., Singleton E.G., Pickworth W.B. Reliability and validity of a Short Form of the Tobacco Craving Questionnaire. Nicotine Tob. Res. 2008, 10:643-651.
36. Heishman S.J., Evans R.J., Singleton E.G., Levin K.H., Copersino M.L., Gorelick D.A. Reliability and validity of a short form of the Marijuana Craving Questionnaire. Drug Alcohol Depend. 2009, 102:35-40.
37. Hughes J. Craving as a psychological construct. Br. J. Addict. 1987, 82:38-39.
38. Hughes J.R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch. Gen. Psychiatry 1986, 43:289-294.
39. Hughes J.R., Hatsukami D. Errors in using tobacco withdrawal scale. Tob. Control 1998, 7:92-93.
40. Hughes J.R., Higgins S.T., Bickel W.K. Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction 1994, 89:1461-1470.
41. Killen J.D., Fortmann S.P. Craving is associated with smoking relapse: findings from three prospective studies. Exp. Clin. Psychopharmacol. 1997, 5:137-142.
42. Killen J.D., Fortmann S.P., Newman B., Varady A. Prospective study of factors influencing the development of craving associated with smoking cessation. Psychopharmacol (Berl.) 1991, 105:191-196.
43. Kober H., Mende-Siedlecki P., Kross E.F., Weber J., Mischel W., Hart C.L., Ochsner K.N. Prefrontal-striatal pathway underlies cognitive regulation of craving. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:14811-14816.
44. Kozlowski L.T., Wilkinson D.A. Use and misuse of the concept of craving by alcohol, tobacco, and drug researchers. Br. J. Addict. 1987, 82:31-45.
45. Littell R.C., Milliken G.A., Stroup W.W., Wolfinger R.D. SAS System for Mixed Models 1996, SAS Institute, Cary, North Carolina.
46. Lo S., Heishman S.J., Raley H., Wright K., Wehring H.J., Moolchan E.T., Feldman S., Liu F., McMahon R.P., Richardson C.M., Kelly D.L. Tobacco craving in smokers with and without schizophrenia. Schizophr. Res. 2011, 127:241-245.
47. McCarthy D.E., Piasecki T.M., Fiore M.C., Baker T.B. Life before and after quitting smoking: an electronic diary study. J. Abnorm. Psychol. 2006, 115:454-466.
48. Metz C.E., Pan X. Proper binormal ROC curves: theory and maximum-likelihood estimation. J. Math. Psychol. 1999, 43:1-33.
49. Metz C.E., Herman B.A., Shen J.-H. Maximum-likelihood estimation of ROC curves from continuously-distributed data. Stat. Med. 1998, 17:1033-1053.
50. Oncken C., Campbell W., Chan G., Hatsukami D., Kranzler H.R. Effects of nicotine patch or nasal spray on nicotine and cotinine concentrations in pregnant smokers. J. Matern. Fetal Neonatal. Med. 2009, 22:751-758.
51. Paliwal P., Hyman S.M., Sinha R. Craving predicts time to cocaine relapse: further validation of the Now and Brief versions of the cocaine craving questionnaire. Drug Alcohol Depend. 2008, 93:252-259.
52. Pesce L.L., Metz C.E. Reliable and computationally efficient maximum-likelihood estimation of "proper" binormal ROC curves. Acad. Radiol. 2007, 14:814-829.
53. Piper M.E., Federmen E.B., McCarthy D.E., Bolt D.M., Smith S.S., Fiore M.C., Baker T.B. Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects. J. Abnorm. Psychol. 2008, 117:94-105.
54. Pitts S.R., Leventhal A.M. Associations of functional and dysfunctional impulsivity to smoking characteristics. J. Addict. Med. 2012, 6:226-232.
55. Powell J., Dawkins L., West R., Powell J., Pickering A. Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacol. (Berl.) 2010, 212:537-549.
56. Rose J.E., McClernon F.J., Froeliger B., Behm F.M., Preud'homme X., Krystal A.D. Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes. Biol. Psychiatry 2011, 70:794-799.
57. Salter K.L., Teasell R.W., Foley N.C., Jutai J.W. Outcome assessment in randomized controlled trials of stroke rehabilitation. Am. J. Phys. Med. Rehabil. 2007, 86:1007-1012.
58. Sayette M.A., Shiffman S., Tiffany S.T., Niaura R.S., Martin C.S., Shadel W.G. The measurement of drug craving. Addiction 2000, 95:S189-S210.
59. Sayette M.A., Martin C.S., Wertz J.M., Shiffman S., Perrott M.A. A multi-dimensional analysis of cue-elicited craving in heavy smokers and tobacco chippers. Addiction 2001, 96:1419-1432.
60. Shadel W.G., Martino S.C., Setodji C., Cervone D., Witkiewitz K., Beckjord E.B., Scharf D., Shih R. Lapse-induced surges in craving influence relapse in adult smokers: an experimental investigation. Health Psychol. 2011, 30:588-596.
61. Shiffman S., Ferguson S.G. The effect of a nicotine patch on cigarette craving over the course of the day: results from two randomized clinical trials. Curr. Med. Res. Opin. 2008, 24:2795-2804.
62. Shiffman S., Kirchner T.R. Cigarette-by-cigarette satisfaction during ad libitum smoking. J. Abnorm. Psychol. 2009, 118:348-359.
63. Shiffman S., Engberg J.B., Paty J.A., Perz W.G., Gnys M., Kassel J.D., Hickcox M. A day at a time: predicting smoking lapse from daily urge. J. Abnorm. Psychol. 1997, 106:104-116.
64. Shiffman S., Khayrallah M., Nowak R. Efficacy of the nicotine patch for relief of craving and withdrawal 7-10 weeks after cessation. Nicotine Tob. Res. 2000, 2:371-378.
65. Shiffman S., West R., Gilbert D. SRNT Work Group on the Assessment of Craving and Withdrawal in Clinical Trials. Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine Tob. Res. 2004, 6:599-614.
66. Shiffman S., Brockwell S.E., Pillitteri J.L., Gitchell J.G. Individual differences in adoption of treatment for smoking cessation: demographic and smoking history characteristics. Drug Alcohol Depend. 2008, 93:121-131.
67. Singleton E.G., Trotman A.J., Zavahir M., Taylor R.C., Heishman S.J. Determination of the reliability and validity of the Marijuana Craving Questionnaire using imagery scripts. Exp. Clin. Psychopharmacol. 2002, 10:47-53.
68. Singleton E.G., Anderson L.M., Heishman S.J. Reliability and validity of the Tobacco Craving Questionnaire and validation of a craving-induction procedure using multiple measures of craving and mood. Addiction 2003, 98:1537-1546.
69. Sivan M., O'Connor R.J., Makower S., Levesley M., Bhakta B. Systematic review of outcome measures used in the evaluation of robot-assisted upper limb exercise in stroke. J. Rehabil. Med. 2011, 43:181-189.
70. SRNT Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 2002, 4:149-159.
71. Swan G.E., Ward M.M., Jack L.M. Abstinence effects as predictors of 28-day relapse in smokers. Addict. Behav. 1996, 21:481-490.
72. Swets J.A. Measuring the accuracy of diagnostic systems. Science 1988, 240:1285-1293.
73. Tiffany S.T. A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychol. Rev. 1990, 97:147-168.
74. Tiffany S.T., Wray J.M. The clinical significance of drug craving. Ann. N. Y. Acad. Sci. 2012, 1248:1-17.
75. Tiffany S.T., Carter B.L., Singleton E.G. Challenges in the manipulation, assessment and interpretation of craving relevant variables. Addiction 2000, 95(Suppl 2):S177-S187.
76. Vogenberg F.R. Predictive and prognostic models: implications for healthcare decision-making in a modern recession. Am. Health Drug. Ben. 2009, 6:218-222.
77. Welsch S.K., Smith S.S., Wetter D.W., Jorenby D.E., Fiore M.C., Baker T.B. Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp. Clin. Psychopharmacol. 1999, 7:354-361.
78. West R., Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacol. (Berl.) 2004, 177:195-199.
79. West R., Schneider N. Craving for cigarettes. Br. J. Addict. 1987, 82:407-415.
80. West R., Ussher M. Is the ten-item Questionnaire of Smoking Urges (QSU-brief) more sensitive to abstinence than shorter craving measures?. Psychopharmacol. (Berl.) 2010, 208:427-432.
81. West R., Ussher M., Evans M., Rashid M. Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales. Psychopharmacol. (Berl.) 2006, 184:619-627.
82. West R., Baker C.L., Cappelleri J.C., Bushmakin A.G. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacol. (Berl.) 2008, 197:371-377.
83. Wyatt J.C., Altman D.G. Prognostic models: clinically useful or quickly forgotten?. Br. Med. J. 1995, 311:1539-1541.
84. Zhou X., Nonnemaker J., Sherrill B., Gilsenan A.W., Coste F., West R. Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict. Behav. 2009, 34:365-373.